These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 21152788)

  • 21. A randomized, blinded, bilateral intraindividual, vehicle-controlled trial of the use of photodynamic therapy with 5-aminolevulinic acid and blue light for the treatment of actinic keratoses of the upper extremities.
    Taub AF; Garretson CB
    J Drugs Dermatol; 2011 Sep; 10(9):1049-56. PubMed ID: 22052276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative study of trichloroacetic acid vs. photodynamic therapy with topical 5-aminolevulinic acid for actinic keratosis of the scalp.
    Di Nuzzo S; Cortelazzi C; Boccaletti V; Zucchi A; Conti ML; Montanari P; Feliciani C; Fabrizi G; Pagliarello C
    Photodermatol Photoimmunol Photomed; 2015 Sep; 31(5):233-8. PubMed ID: 25660106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized, double-blind, placebo-controlled clinical trial evaluating the role of systemic antihistamine therapy for the reduction of adverse effects associated with topical 5-aminolevulinic acid photodynamic therapy.
    Vanaman Wilson MJ; Jones IT; Wu DC; Goldman MP
    Lasers Surg Med; 2017 Oct; 49(8):738-742. PubMed ID: 28489298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. delta-Aminolevulinic acid and blue light photodynamic therapy for treatment of multiple basal cell carcinomas in two patients with nevoid basal cell carcinoma syndrome.
    Itkin A; Gilchrest BA
    Dermatol Surg; 2004 Jul; 30(7):1054-61. PubMed ID: 15209801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Daylight-mediated photodynamic therapy of moderate to thick actinic keratoses of the face and scalp: a randomized multicentre study.
    Wiegell SR; Fabricius S; Gniadecka M; Stender IM; Berne B; Kroon S; Andersen BL; Mørk C; Sandberg C; Ibler KS; Jemec GB; Brocks KM; Philipsen PA; Heydenreich J; Hædersdal M; Wulf HC
    Br J Dermatol; 2012 Jun; 166(6):1327-32. PubMed ID: 22250644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Retrospective, descriptive, observational study of treatment of multiple actinic keratoses with topical methyl aminolevulinate and red light: results in clinical practice and correlation with fluorescence imaging].
    Fernández-Guarino M; Harto A; Sánchez-Ronco M; Pérez-García B; Marquet A; Jaén P
    Actas Dermosifiliogr; 2008 Dec; 99(10):779-87. PubMed ID: 19091216
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Daylight photodynamic therapy with methyl aminolevulinate cream as a convenient, similarly effective, nearly painless alternative to conventional photodynamic therapy in actinic keratosis treatment: a randomized controlled trial.
    Rubel DM; Spelman L; Murrell DF; See JA; Hewitt D; Foley P; Bosc C; Kerob D; Kerrouche N; Wulf HC; Shumack S
    Br J Dermatol; 2014 Nov; 171(5):1164-71. PubMed ID: 24861492
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized Vehicle-Controlled Study of Short Drug Incubation Aminolevulinic Acid Photodynamic Therapy for Actinic Keratoses of the Face or Scalp.
    Pariser DM; Houlihan A; Ferdon MB; Berg JE;
    Dermatol Surg; 2016 Mar; 42(3):296-304. PubMed ID: 26863596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Continuous activation of PpIX by daylight is as effective as and less painful than conventional photodynamic therapy for actinic keratoses; a randomized, controlled, single-blinded study.
    Wiegell SR; Haedersdal M; Philipsen PA; Eriksen P; Enk CD; Wulf HC
    Br J Dermatol; 2008 Apr; 158(4):740-6. PubMed ID: 18294318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fingernail photo-onycholysis after aminolevulinic acid-photodynamic therapy under blue light for treatment of actinic keratoses on the face.
    Paci K; Bell RT; Goldstein B
    Cutis; 2016 Aug; 98(2):E10-1. PubMed ID: 27622260
    [No Abstract]   [Full Text] [Related]  

  • 31. A randomized comparative study of tolerance and satisfaction in the treatment of actinic keratosis of the face and scalp between 5% imiquimod cream and photodynamic therapy with methyl aminolaevulinate.
    Serra-Guillen C; Nagore E; Hueso L; Llombart B; Requena C; Sanmartín O; Botella-Estrada R; Guillen C
    Br J Dermatol; 2011 Feb; 164(2):429-33. PubMed ID: 20973770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topical methyl-aminolevulinate photodynamic therapy using red light-emitting diode light for treatment of multiple actinic keratoses: A randomized, double-blind, placebo-controlled study.
    Pariser D; Loss R; Jarratt M; Abramovits W; Spencer J; Geronemus R; Bailin P; Bruce S
    J Am Acad Dermatol; 2008 Oct; 59(4):569-76. PubMed ID: 18707799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A trial of short incubation, broad-area photodynamic therapy for facial actinic keratoses and diffuse photodamage.
    Touma D; Yaar M; Whitehead S; Konnikov N; Gilchrest BA
    Arch Dermatol; 2004 Jan; 140(1):33-40. PubMed ID: 14732657
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Short incubation with methyl aminolevulinate for photodynamic therapy of actinic keratoses.
    Braathen LR; Paredes BE; Saksela O; Fritsch C; Gardlo K; Morken T; Frølich KW; Warloe T; Solér AM; Ros AM
    J Eur Acad Dermatol Venereol; 2009 May; 23(5):550-5. PubMed ID: 19415804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Photodynamic therapy with aminolevulinic acid topical solution and visible blue light in the treatment of multiple actinic keratoses of the face and scalp: investigator-blinded, phase 3, multicenter trials.
    Piacquadio DJ; Chen DM; Farber HF; Fowler JF; Glazer SD; Goodman JJ; Hruza LL; Jeffes EW; Ling MR; Phillips TJ; Rallis TM; Scher RK; Taylor CR; Weinstein GD
    Arch Dermatol; 2004 Jan; 140(1):41-6. PubMed ID: 14732659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Daylight photodynamic therapy for actinic keratoses: a randomized double-blinded nonsponsored prospective study comparing 5-aminolaevulinic acid nanoemulsion (BF-200) with methyl-5-aminolaevulinate.
    Neittaanmäki-Perttu N; Karppinen TT; Grönroos M; Tani TT; Snellman E
    Br J Dermatol; 2014 Nov; 171(5):1172-80. PubMed ID: 25109244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short incubation photodynamic therapy with methylaminolevulinate and no occlusion for the treatment of actinic keratoses.
    Bissonnette R; Bolduc C; Maari C; Nigen S
    J Am Acad Dermatol; 2012 Dec; 67(6):1386-7. PubMed ID: 23158619
    [No Abstract]   [Full Text] [Related]  

  • 38. A randomized controlled clinical trial of topical photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratoses in transplant recipients.
    Dragieva G; Prinz BM; Hafner J; Dummer R; Burg G; Binswanger U; Kempf W
    Br J Dermatol; 2004 Jul; 151(1):196-200. PubMed ID: 15270891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Consensus recommendations on the use of daylight photodynamic therapy with methyl aminolevulinate cream for actinic keratoses in Australia.
    See JA; Shumack S; Murrell DF; Rubel DM; Fernández-Peñas P; Salmon R; Hewitt D; Foley P; Spelman L
    Australas J Dermatol; 2016 Aug; 57(3):167-74. PubMed ID: 26033230
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term Outcome of Daylight Photodynamic Therapy with Amino-5-laevulinate Nanoemulsion vs. Methyl-5-aminolaevulinate for Actinic Keratoses.
    Neittaanmäki-Perttu N; Grönroos M; Tani T; Snellman E
    Acta Derm Venereol; 2016 Jun; 96(5):712-3. PubMed ID: 26806126
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.